Next Article in Journal
Molecular Determination of Mixed Infections of Dermatophytes and Nondermatophyte Molds in Individuals with Onychomycosis
Previous Article in Journal
Acceptance Address, APMA House of Delegates, Washington, DC, March 16, 2014
 
 
Journal of the American Podiatric Medical Association is published by MDPI from Volume 116 Issue 1 (2026). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with American Podiatric Medical Association.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Impact of Glycosylated Hemoglobin and Diabetes Mellitus on Wound-Healing Complications and Infection After Foot and Ankle Surgery

by
Jon M. Humphers
1,*,
Naohiro Shibuya
1,2,
Benjamin L. Fluhman
1 and
Daniel Jupiter
1,2
1
Scott and White Memorial Hospital, Texas A&M Health Science Center, Temple, TX. Dr. Humphers is now with Chickasaw Nation Medical Center, Ada, OK. Dr. Fluhman is now with Grace Clinic, Lubbock, TX
2
Department of Surgery, Texas A&M Health and Science Center, College of Medicine, Temple, TX
*
Author to whom correspondence should be addressed.
J. Am. Podiatr. Med. Assoc. 2014, 104(4), 320-329; https://doi.org/10.7547/0003-0538-104.4.320
Published: 1 July 2014

Abstract

Background: The relationship between hyperglycemia and adverse outcomes after surgery has been widely documented. Long-term glucose control has been recognized as a risk factor for postoperative complications. In the foot and ankle literature, long-term glycemic control as a potential perioperative risk factor is not well studied. Our goal was to investigate whether hemoglobin A1c (HbA1c) level was independently associated with postoperative complications in a retrospective cohort study. Methods: Three hundred twenty-two patients with a diagnosis of diabetes mellitus were enrolled in the study to assess risk factors associated with postoperative foot and ankle surgery complications. Results: Bivariate analyses showed that HbA1c level and having at least one comorbidity were associated with postoperative infections. However, after adjusting for other covariates, the only significant factor was HbA1c level, with each increment of 1% increasing the odds of infection by a factor of 1.59 (95% confidence interval [CI], 1.28–1.99). For postoperative wound-healing complications, bivariate analyses showed that body mass index, having at least one comorbidity, and HbA1c level were significant factors. After adjusting for other covariates, the only significant factors for developing postoperative wound complications were having at least one comorbidity (odds ratio, 2.03; 95% CI, 1.22–3.37) and HbA1c level (each 1% increment) (odds ratio, 1.25; 95% CI, 1.02–1.53). Conclusions: In this retrospective study, HbA1c level had the strongest association with postoperative foot and ankle surgery complications in patients with diabetes.

The relationship between hyperglycemia and adverse outcomes after surgery has been widely documented, particularly regarding infectious complications.[1-7] Most of these studies have focused on patients with a history of diabetes mellitus. Patients with diabetes mellitus are at a higher risk for infection compared with those without diabetes. Long-term glucose control as measured by hemoglobin A1c (HbA1c) level has been recognized as a major risk factor after coronary artery procedures and myocardial infarction and for a significantly higher incidence of 30-day morbidity after vascular surgery procedures.[6-10] Similarly, perioperative hyperglycemia, measured by finger stick and serum glucose level, has been shown to be an independent risk factor for postoperative complications.[1,2,5,11] Moitra and colleagues[12] documented the relationship between HbA1c level and perioperative glucose control in noncardiac surgery patients. They found that long-term glycemic control affected perioperative glucose control and that patients with poor preoperative glycemic control (HbA1c level ≥7% [≥53 mmol/mol]) had higher perioperative glucose levels compared with patients with HbA1c levels less than 7% (<53 mmol/mol). They concluded that although perioperative glucose level was a stronger predictor of postoperative control, diabetic patients can be more easily screened with HbA1c level well in advance of surgery.
In reviewing the foot and ankle literature in particular, there are few studies evaluating long-term glycemic control as a potential perioperative risk. Poorly controlled and complicated diabetes has been shown to be a significant risk factor for infection after foot and ankle surgery.[13-15] Myers and colleagues,[13] in their comparison of ankle and hindfoot fusions in patients with and without diabetes, found that patients with diabetes and an HbA1c level greater than or equal to 7% (≥53 mmol/mol) had a statistically significantly higher postoperative infection rate. The other studies considered cases involving treatment for diabetic foot infections. Younger et al[15] determined that HbA1c level was an important determinant of the healing rate after a transmetatarsal amputation. They determined that an HbA1c level of 10% (86 mmol/mol) was a threshold above which healing was poor. They emphasized the necessity of obtaining HbA1c levels on initial consultation, and they recommended delaying surgery until daily glycemic control was acceptable. Lepore et al[16] found that patients who underwent amputation for diabetic foot ulcerations had a significantly higher HbA1c level than those without amputation. Conversely, Aragon-Sanchez and Lazaro-Martinez[17] determined in their study of surgical treatment of osteomyelitis in diabetic feet that perioperative glycemic control was a predictive factor for amputation, whereas long-term glycemic control was not.
Patients with diabetes mellitus, especially when the disease is poorly controlled, may have associated comorbid conditions that place them at higher risk for postoperative complications. Postoperative complications lead to higher health-care costs and poorer overall outcomes. To our knowledge, no previous multivariate analysis based on HbA1c levels of surgical outcomes of diabetic patients after a wide array of foot and ankle surgical procedures has been performed. Understanding the association between HbA1c and postoperative complications may help guide surgical decision making.

Research Design and Methods

The study was approved by the institutional review board of Scott and White Healthcare (Temple, Texas). A query of electronic medical records was performed to identify all of the diabetic patients who had undergone foot or ankle surgery between January 1, 2007, and December 31, 2011, at four Scott and White Healthcare facilities (Temple, Waco, Round Rock, and Bryan/College Station, Texas). We used Current Procedural Terminology (CPT 2008; American Medical Association, Chicago, Illinois) codes 27600 to 28899 and International Classification of Diseases, Ninth Revision (World Health Organization, Geneva, Switzerland) codes 250.0 to 250.9 to extract the data from electronic medical records. Patient medical records were reviewed for inclusion and exclusion criteria (Table 1). Multiple variables were then collected as noted in Tables 2 and 3. Body mass index (BMI) (the weight in kilograms divided by the square of the height in meters) was calculated from the preoperative height and weight measurements recorded by an anesthesiologist.
Table 1. Inclusion and Exclusion Criteria
Table 1. Inclusion and Exclusion Criteria
Japma 104 00320 i001
Table 2. Surgical Wound Classification of Garner[18] and Simmons[19]
Table 2. Surgical Wound Classification of Garner[18] and Simmons[19]
Japma 104 00320 i002
Table 3. Perioperative, Intraoperative, and Postoperative Variables Collected
Table 3. Perioperative, Intraoperative, and Postoperative Variables Collected
Japma 104 00320 i003
The diagnosis of diabetes mellitus was made during the preoperative evaluation on the basis of the history. All of the patients had to be receiving pharmacological therapy for diabetes to be included in the study. Medical records were used to determine the presence of the following comorbid conditions: peripheral neuropathy, previous foot ulceration, peripheral vascular disease, and smoking history. Patients were diagnosed as having peripheral sensory neuropathy if they had any sensory deficit noted, regardless of degree or the test used to diagnose neuropathy. Peripheral vascular disease was based on diagnosis or nonpalpable pulses. Patients were considered to have a positive tobacco history if they were currently smoking at their preoperative history and physical examination documented in the medical record. A postoperative infection was defined as an infection that occurred within 30 days after surgery. The severity of the surgical site infection was defined as superficial incisional and deep incisional as defined by the Centers for Disease Control and Prevention.[20] Wound complications included wound dehiscence, hematoma/seroma, bulla formation, and persistent wound drainage more than 3 weeks after surgery.
Elective and emergency surgeries were included. Forefoot procedures included procedures for hallux valgus, hallux limitus, hammertoe correction, open reduction and internal fixation, metatarsal fractures (including Lisfranc fracture), lesser metatarsal osteotomies (metadductus correction, Weil osteotomies, Tailor bunionectomy, etc), neurectomies, soft-tissue mass excision (ganglion cyst, fibroma, etc), and tarsometatarsal joint arthrodesis. Rearfoot procedures included, but were not limited to, fracture repair (ankle, calcaneal, cuboid, etc), hindfoot arthrodesis (tibiotalocalcaneal, ankle, pantalar, triple, subtalar, pseudotriple, etc), Achilles tendon debridement/repair, tarsal tunnel release, ankle arthroplasty, plantar fascial release, and osteotomies (flatfoot or cavus foot reconstruction).
For patients who had a postoperative infection, a return to the operating room for subsequent surgical intervention was not included in the data analysis.

Analysis of Data

The prevalence of postoperative infection and wound complications were the study's primary dependent variables and were calculated for patients with diabetes mellitus undergoing foot and ankle surgery.
Student t tests/analyses of variance or χ2/Fisher exact tests, as appropriate, were performed to compare those with and without complication in terms of the various preoperative and operative variables. A logistic regression model for the occurrence of complications was then built, including any covariates that reached a significance level of 0.2 on the bivariate analyses previously herein. Hemoglobin A1c, age, and sex were included in the model regardless of the results of the bivariate analyses. Exploratory analyses were performed after analysis of the data. These analyses are meant to be illustrative and informative rather than providing conclusive evidence. Statistical analyses were performed using the R statistical package (http://www.R-project.org).

Results

A total of 3,795 patients were identified after an initial search of electronic medical records. After screening for the inclusion and exclusion criteria, we identified 322 patients with a diagnosis of diabetes mellitus who had undergone foot and ankle surgery. Most of the patients were excluded owing to lack of laboratory values, insufficient follow-up, having an infection or undergoing antibiotic drug therapy at the time of operation, or a combination of one or more of these factors. The age of the patients ranged from 29 to 80 years (mean ± SD, 60.2 ± 10.39 years). Of the patients, 225 were men (69.9%) and 97 were women (30.1%). There were 222 (68.9%), 57 (17.7%), 38 (11.8%), 2 (0.6%), 2 (0.6%), 1 (0.3%), and 0 white, other, African American, Hispanic, unknown, Asian, and American Indian patients, respectively. Two patients were missing BMI, and for the remainder, the mean ± SD BMI was 33.8 ± 7.56 (range, 19.2–59.6). Twenty-four (7.5%), 126 (39.1%), 49 (15.2%), 72 (22.4%), and 163 (50.6%) patients had peripheral vascular disease, peripheral neuropathy, a smoking history, a history of ulcer, or at least one of the previous comorbidities, respectively.
Surgery time was missing for 29 patients, and for the remainder the mean ± SD time was 75.1 ± 49.96 min (range, 3–327 min). The mean ± SD HbA1c value was 7.5% ± 1.65% (range, 4.8%–15.9%), or 58 mmol/mol. Glucose level was missing for 27 patients, and for the remainder the mean ± SD level was 160.6 ± 64.24 mg/dL (range, 41–572 mg/dL).
Of the procedures, 7 (2.2%), 186 (57.8%), and 129 (40.1%) were both forefoot and rearfoot/ankle, forefoot only, and rearfoot/ankle only, respectively. Sixty-three (19.6%), 199 (61.8%), and 60 (18.6%) of the procedures were both osseous and soft tissue, osseous only, and soft tissue only, respectively. According to the surgical wound classification in Table 2, 287 (89.1%), 34 (10.6%), and 1 (0.3%) were clean, clean-contaminated, or other, respectively. There were 3 deep venous thrombosis/pulmonary emboli (0.9%).
There were 74 superficial (23.0%) and 19 deep (5.9%) postoperative infections and 229 procedures (71.1%) with no infection. This is a total of 93 infections (28.9%). There were 116 other wound complications (36.0%). Five patients (1.6%) developed Charcot arthropathy. There were 11 ipsilateral amputations (3.4%).

Bivariate Analyses

Infection

Of the 159 patients with no comorbidity, 34 (21.4%) had an infection, and among the 163 patients with at least one comorbidity, 59 (36.2%) had a complication. This was χ[2] test significant (P = .003). The mean ± SD HbA1c level in patients with infection was 8.3% ± 1.89%, or 67 mmol/mol, and in those without complication, it was 7.2% ± 1.44%, or 55 mmol/mol. This was t test significant (P < .001). The remaining variables were not statistically significant (Table 4).
Table 4. Bivariate Analysis of Infection Complication
Table 4. Bivariate Analysis of Infection Complication
Japma 104 00320 i004

Wound Complications

Patients with complications had a mean ± SD BMI of 34.9 ± 7.46; in those without complications, mean ± SD BMI was 33.1 ± 7.55. This was t test significant (P = .043). Of the 159 patients with no comorbidity, 40 (25.2%) had a complication, and of the 163 patients with at least one comorbidity, 76 (46.6%) had a complication. This was χ[2] test significant (P < .001). The mean ± SD HbA1c level in those with complications was 8.1% ± 1.77%, or 65 mmol/mol, and in those without complications it was 7.2% ± 1.50%, or 55 mmol/mol. This was t test significant (P < .001). The remaining variables were not significant (Table 5).
Table 5. Bivariate Analysis of Wound Complications
Table 5. Bivariate Analysis of Wound Complications
Japma 104 00320 i005

Logistic Regression Analyses

Infection

Using a logistic regression model for infection with the covariates age, sex, race, BMI, presence of any comorbidity, HbA1c level, serum glucose level, and type of procedure (osseous/soft tissue), the only significant factor was HbA1c level. Each 1% increase in HbA1c increased the odds of infection by a factor of 1.59 (95% confidence interval [CI], 1.28–1.99).

Wound Complications

In a logistic regression model for wound complications with the covariates age, sex, race, BMI, presence of any comorbidity, HbA1c level, and serum glucose level, the only significant factors were HbA1c level, with each 1% increase in HbA1c increasing the odds of wound-healing complication by a factor of 1.25 (95% CI, 1.02–1.53), and presence of any comorbidity (odds ratio, 2.03; 95% CI, 1.22–3.37).

Discussion

This retrospective study showed that a higher HbA1c level was associated with an increased risk of infection and wound-healing complications after foot and ankle surgery. The mean HbA1c levels for those with and without a postoperative infection were 7.2% (55 mmol/mol) and 8.3% (67 mmol/mol), respectively. For those with and without postoperative wound complications, these levels were 7.2% (55 mmol/mol) and 8.1% (65 mmol/mol), respectively. In the literature, the relationship between HbA1c levels and surgical infections is not consistent. No significant relationship was demonstrated after total joint arthroplasty,[21] penile prosthesis,[22] and other major surgical procedures,[4,23] whereas other studies have shown a relationship with postoperative complications.[6-10,13,15,16,24,25]
Perioperative serum glucose measurement has been advocated to be a stronger predictor of postoperative complication in several studies.[1,2,7,13,17,23,25-28] However, in the present study, perioperative glucose measurement did not have any statistically significant association with postoperative infection (174 mg/dL with and 155 mg/dL without) or wound-healing complication (175 mg/dL with and 152 mg/dL without). One explanation for this contradiction is that most of the previously cited studies involved high-risk surgical procedures, whereas the present data included all aspects of foot and ankle procedures, including elective procedures. As well, in many cases, there were potentially multiple perioperative glucose laboratory values. It was up to the reviewer to determine which value to extract. If the perioperative glucose value was the immediate preoperative or fasting glucose level, this may not have been an adequate representation of daily glucose levels. In addition, if immediate postoperative values were obtained, this may have been misleading because perioperative glucose levels can be inflated secondary to surgical stress. Although some literature supports tight perioperative glycemic control,[29,30] it remains a controversial topic because a randomized controlled trial assessing intraoperative glucose control did not demonstrate added benefit for tight management.[31]
Having at least one comorbidity was also significantly associated with developing a postoperative infection in the present study. In this cohort, 63.4% (59 of 93) of those with postoperative infection had one or more comorbidities. Specifically, after post hoc exploration of the data, having neuropathy was significantly associated with developing postoperative infection (χ2 P < .001). Fifty-six percent (52 of 93) of those with postoperative infection had neuropathy. This is in agreement with other authors, who show that peripheral neuropathy is a risk factor for postoperative infection.[13,32-35]
In analyzing postoperative wound complications, BMI, one or more comorbidities, and HbA1c level were found to be significant risk factors in bivariate analysis. When comorbidities were broken down, BMI (P < .043), peripheral neuropathy (P < .001), and tobacco use (P < .040) were significantly associated with wound complications in the bivariate analysis. However, after adjusting for other covariates, only HbA1c level and one or more comorbidities were significant risk factors. Several authors have demonstrated that obesity has a deleterious effect after orthopedic trauma.[36-41] Karuncher et al[36] and Porter et al[39] showed that obese patients were at increased risk for the development of a wound complication after surgery. Graves et al[41] found in their study that obesity had a trend toward association with wound-healing complications. Increased tension on the fascial edges at the time of closure, with associated increased tissue pressure, which, in turn, reduces microperfusion and oxygen, has been suggested to cause surgical dehiscence in obese patients.[42,43] Hematoma and seroma formation are additional risks for obese patients. Armstrong[44] found that obese patients were more prone to hematoma formation, with delayed healing and decreased tissue oxygenation. Although these studies were not specifically on patients with diabetes, one could presume that this holds true in diabetic patients. In the present study, BMI was not significantly associated with postoperative complications. This may be due to the obese cohort (mean BMI = 33.2) with a small low BMI population.
After post hoc exploration of the data, we discovered an association between smoking and postoperative wound complications (24 of 49 [49.0%]). The impact of smoking on wound-healing complications has been well studied. Sorensen,[45] in a systematic review, discussed three harmful mechanisms of smoking on wound healing: 1) a temporary reduction in tissue perfusion and oxygenation, 2) impairment of inflammatory cell functions and oxidative bactericidal mechanisms, and 3) attenuation of reparative cell functions, including synthesis and deposition of collagen. It was concluded that this attenuation of inflammation and proliferation was responsible for the higher incidence of wound-healing complications. Increased awareness, early recognition, and treatment of wound complications in the postoperative period is warranted because smoking can only further increase the risk of complication.
We recognize several shortcomings in this study. First, the retrospective nature of this study limits the accuracy of the data collected from the medical records. A drawback to the definitions of peripheral neuropathy, peripheral vascular disease, and smoking history are that these are vague and depend on physician preference in history and physical examinations. We recognize the shortcoming of measuring preoperative glucose levels within 30 days of surgery, as this is a broad time frame. Although most of these measurements were taken the day of surgery, this could not be guaranteed for all of the patients because there is no standard time frame before surgery within which they must have had a glucose read. We felt that complications reported in the medical records were more reliable than effectiveness or success measured subjectively by each surgeon. Although it is still possible that complications can be underreported, they would not be overdocumented. Those with less than 3 months of follow-up, who were not included in the study, might also have had undocumented complications occurring after the last visit. Therefore, the true rate of complication might have been higher than what we reported. Second, we did not determine whether insulin-dependent diabetic patients had worse postoperative wound complications than those controlled with diet or oral hypoglycemic medications. Only patients with a history of pharmacologically controlled diabetes reported preoperatively were included in the study. This may be important because these medications have metabolic effects outside of just reducing serum glucose levels. Third, surgeons were not blinded to patients' diabetes state before the operation. Surgeons select patients and change the surgical plan according to patients' medical history. For example, one may minimize soft-tissue dissection in exchange for anatomical reduction in a trauma case if one knows that the patient's diabetes is not well controlled. As well, the reviewers were not blinded regarding other variables, and bias stemming from knowing other results may have affected the final result.
In addition, many diabetic patients, owing to lack of HbA1c measurements, were excluded from this study. This may disproportionally exclude noncompliant, high-risk patients because they are less likely to keep appointments and undergo laboratory tests. This may have resulted in undersampling of noncompliant, high-risk patients in elective cases because surgeons would be less likely to operate on those patients. On the other hand, healthy, well-controlled diabetic patients may not have HbA1c levels evaluated regularly; therefore, many of them may have been excluded in this study. Whereas undersampling of healthy patients may have caused underestimation, oversampling of high-risk, noncompliant patients in emergency (higher-risk) cases may have overestimated the effect of HbA1c level on postoperative complications. This is a limitation to the study, but we are trying to identify risk factors as opposed to determine the incidence of postoperative complications.
Note that this study included emergency cases. Stress-induced hyperglycemia after musculoskeletal injuries is not a new concept. Stress-induced hyperglycemia refers to an elevation of blood glucose levels during times of illness.[46,47] In a small series of patients without a history of diabetes, Funsten[48] noted an immediate increase in blood glucose levels after injury. Richards et al[28] found that hyperglycemia was an independent risk factor for surgical site infection in orthopedic trauma patients without a history of diabetes. Therefore, the mean perioperative serum glucose level may have been artificially elevated in the emergency cases. Assuming that the emergency cases have more postoperative complications, the effect of serum glucose level could have been inflated in this cohort. Nonetheless, we did not detect association between perioperative serum glucose level and postoperative complications in this study.
The strengths of this study are that 1) all of the study sites had nearly identical strict perioperative protocols; as a result, patients received uniform infection precautions, antibiotic prophylaxis, and thrombophylaxis and 2) we were able to adjust for other variables that may have confounded the effect of HbA1c level, providing a clearer view of the impact of HbA1c level on postoperative complications in patients with diabetes.

Conclusions

Within the limitations of the study, HbA1c level was associated with the occurrence of infection and wound complication after foot and ankle surgery, after adjusting for other covariates. We conclude that diabetic patients have an associated risk of postoperative complications; long-term glucose control as determined by HbA1c level conveys risk of postoperative complications. Further investigation into the impact of long-term glycemic control and postoperative outcomes is warranted to identify a reasonable cutoff point below which foot and ankle surgery can be safely performed.
Based on the results of this study, we recommend obtaining an HbA1c measurement on initial consultation regardless of serum glucose level because HbA1c provides a good impression of potential postoperative sequelae. This is in contrast to a random glucose measurement, which can be influenced by any variety of stresses. Our approach to elective surgery in patients with uncontrolled diabetes mellitus will be to delay surgery in patients until better glycemic control can be obtained. Although an HbA1c level less than 7% may be ideal, it may not always be practical, and a more thorough counseling session must then be performed preoperatively to discuss other factors predictive of postoperative complications. Furthermore, for uncontrolled diabetic patients requiring more urgent surgery, we recommend earlier and more frequent postoperative follow-up and increased vigilance for postoperative infections and early wound complications.

Acknowledgment

The reviewer for very helpful and insightful comments during the editing process.

Financial Disclosure

None reported.

Conflict of Interest

None reported.

References

  1. RichardsJE, KauffmannRM, ZuckermanSL, et al: Relationship of hyperglycemia and surgical-site infection in orthopaedic surgery. J Bone Joint Surg Am94: 1181, 2012.
  2. MraovicB, DonghunS, JacovidesC, et al: Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty. J Diabetes Sci Technol5: 412, 2011.
  3. LamloumSM, MobasherLA, KararAH, et al: Relationship between postoperative infectious complications and glycemic control for diabetic patients in an orthopedic hospital in Kuwait. Med Princ Pract18: 447, 2009.
  4. AcottAA, TheusSA, KimLT:Long-term glucose control and risk of perioperative complications. Am J Surg198: 596, 2009.
  5. MarchantMH, ViensNA, CookC, et al: The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am91: 1621, 2009.
  6. DrongeAS, PerkalMF, KancirS, et al: Long-term glycemic control and postoperative infectious complications. Arch Surg141: 375, 2006.
  7. GoldenSH, KaoWH, Peart-VigilanceC, et al: Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care22: 1408, 1999.
  8. HalkosME, PuskasJD, LattoufOM, et al: Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg136: 631, 2008.
  9. CakmakM, CakmakN, CetemenS, et al: The value of admission glycosylated hemoglobin level in patients with acute myocardial infarction. Can J Cardiol24: 375, 2008.
  10. O'SullivanCJ, HynesN, MahendranB, et al: Haemoglobin A1c (HgbA1c) in non-diabetic and diabetic vascular patients: is HgbA1c an independent risk factor and predictor of adverse outcome?Eur J Vasc Endovasc Surg32: 188, 2006.
  11. NoordziiPG, BoersmaE, SchreinerF, et al: Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery. Eur J Endocrinol156: 137, 2007.
  12. MoitraVK, GreenburgJ, ArunajadaiS, et al: The relationship bewteen glycosylated hemoglobin and perioperative glucose control in patients with diabetes. Can J Anesth57: 322, 2010.
  13. MyersTG, LoweryNJ, FrykbergRG, et al: Ankle and hindfoot fusions: comparison of outcomes in patients with and without diabetes. Foot Ankle Int33: 20, 2012.
  14. WukichDK, LoweryNJ, McMillenRL, et al: Postoperative infection rates in foot and ankle surgery: a comparison of patients with and without diabetes mellitus. J Bone Joint Surg Am92: 287, 2010.
  15. YoungerAS, AwwadMA, KallaTP, et al: Risk factors for failure of transmetatarsal amputation in diabetic patients: a cohort study. Foot Ankle Int30: 1177, 2009.
  16. LeporeG, MaglioML, CuniC, et al: Poor glucose control in the year before admission as a powerful predictor of amputation in hospitalized patients with diabetic foot ulceration. Diabetes Care29: 1985, 2006.
  17. Aragon-SanchezJ, Lazaro-MartinezJL:Impact of peroperative glycaemia and glycated haemoglobin on the outcomes of the surgical treatment of diabetic foot osteomyelitis. Diabetes Res Clin Pract94: e83, 2011.
  18. GarnerJS:CDC guideline for prevention of surgical wound infections, 1985: supercedes guideline for prevention of surgical wound infections published in 1982: (originally published in 1995): revised. Infect Control7: 193, 1986.
  19. SimmonsBP:Guideline for prevention of surgical wound infections. Infect Control3: 185, 1982.
  20. HoranTC, GaynesRP, MartoneWJ, et al: CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol13: 606, 1992.
  21. IorioR, WilliamsKM, MarcantonioAJ, et al: Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J Arthroplasty27: 726, 2012.
  22. WilsonSK, CarsonCC, ClevesMA, et al: Quantifying risk of penile prosthesis infection with elevated glycosylated hemoglobin. J Urol159: 1537, 1998.
  23. KingJTJr, GouletJL, PerkalMF, et al: Glycemic control and infections in patients with diabetes undergoing noncardiac surgery. Ann Surg253: 158, 2011.
  24. BishopJR, MoulJW, SihelnikSA, et al: Use of glycosylated hemoglobin to identify diabetics at high risk for penile periprosthetic infections. J Urol147: 386, 1992.
  25. LathamR, LancasterAD, CovingtonJF, et al: The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol22: 607, 2001.
  26. SmithDK, BowenJ, BucherL, et al: A study of perioperative hyperglycemia in patients with diabetes having colon, spine, and joint surgery. J Perianesth Nurs24: 362, 2009.
  27. JamsenE, NavalainenP, KalliovalkamaJ, et al: Preoperative hyperglycemic predicts infected total knee replacement. Eur J Int Med21: 196, 2010.
  28. RichardsJE, KauffmannRM, ZuckermanSL, et al: Relationship of hyperglycemia and surgical-site infection in orthopaedic surgery. J Bone Joint Surg Am94: 1181, 2012.
  29. van den BergheG, WoutersP, WeekersF, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med345: 1359, 2001.
  30. FinferS, ChittockDR, SuSY, et al: NICE-SUGAR Study Investigators: Intensive versus conventional glucose control in critically ill patients. N Engl J Med360: 1283, 2009.
  31. GandhiGY, NuttallGA, AbelMD, et al: Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med146: 233, 2007.
  32. ArmstrongDG, LaveryLA, FrykbergRG, et al: Validation of a diabetic foot surgery classification. Int Wound J3: 240, 2006.
  33. WukichDK, LoweryNJ, McMillenRL, et al: Postoperative infection rates in foot and ankle surgery: a comparison of patients with and without diabetes mellitus. J Bone Joint Surg Am92: 287, 2010.
  34. WukichDK, LoweryNJ, McMillenRL, et al: Surgical site infections after foot and ankle surgery. Diabetes Care34: 2211, 2011.
  35. CostiganW, ThoradsonDB, DebnathUK:Operative management of ankle fractures in patients with diabetes mellitus. Foot Ankle Int28: 32, 2007.
  36. KarunakarMA, ShahSN, JerabekS:Body mass index as a predictor of complications after operative treatment of acetabular fractures. J Bone J Surg Am87: 1498, 2005.
  37. PorterSE, GravesML, QinZ, et al: Operative experience of pelvic fractures in the obese. Obes Surg18: 702, 2008.
  38. TuckerMS, SchwappachJR, LeightonRK, et al: Results of femoral intramedullary nailing in patients who are obese versus those who are not obese: a prospective multicenter comparison study. J Orthop Trauma21: 523, 2007.
  39. PorterSE, RusselGV, DewsRC, et al: Complications of acetabular fracture surgery in morbidly obese patients. J Orthop Trauma22: 589, 2008.
  40. BostmanOM:Body-weight related to loss of reduction of fractures of the distal tibia and ankle. J Bone Joint Surg Br77: 101, 1995.
  41. GravesML, PorterSE, FaganBC, et al: Is obesity protective against wound healing complications in pilon surgery? Soft tissue envelope and pilon fractures in the obese. Orthopedics2010. doi:10.3928/01477447-20100625-27.
  42. DerzieAJ, SilvestriF, LirianoE, et al: Wound closure technique and acute wound complications in gastric surgery for morbid obesity: a prospective randomized trial. J Am Coll Surg191: 238, 2000.
  43. HopfHW, HuntTK, WestJM, et al: Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg132: 997, 1997.
  44. ArmstrongM:Obesity as an intrinsic factor affecting wound healing. J Wound Care7: 220, 1998.
  45. SorensenLT:Wound healing and infection in surgery: the pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy: a systematic review. Ann Surg255: 1069, 2012.
  46. McCowenKC, MalhotraA, BistrianBR:Stress-induced hyperglycemia. Crit Care Clin17: 107, 2001.
  47. DunganKM, BraithwaiteSS, PreiserJC:Stress hyperglycaemia. Lancet373: 1798, 2009.
  48. FunstenRV:The effect of fractures on blood sugar. J Bone Joint Surg17: 769, 1935.

Share and Cite

MDPI and ACS Style

Humphers, J.M.; Shibuya, N.; Fluhman, B.L.; Jupiter, D. The Impact of Glycosylated Hemoglobin and Diabetes Mellitus on Wound-Healing Complications and Infection After Foot and Ankle Surgery. J. Am. Podiatr. Med. Assoc. 2014, 104, 320-329. https://doi.org/10.7547/0003-0538-104.4.320

AMA Style

Humphers JM, Shibuya N, Fluhman BL, Jupiter D. The Impact of Glycosylated Hemoglobin and Diabetes Mellitus on Wound-Healing Complications and Infection After Foot and Ankle Surgery. Journal of the American Podiatric Medical Association. 2014; 104(4):320-329. https://doi.org/10.7547/0003-0538-104.4.320

Chicago/Turabian Style

Humphers, Jon M., Naohiro Shibuya, Benjamin L. Fluhman, and Daniel Jupiter. 2014. "The Impact of Glycosylated Hemoglobin and Diabetes Mellitus on Wound-Healing Complications and Infection After Foot and Ankle Surgery" Journal of the American Podiatric Medical Association 104, no. 4: 320-329. https://doi.org/10.7547/0003-0538-104.4.320

APA Style

Humphers, J. M., Shibuya, N., Fluhman, B. L., & Jupiter, D. (2014). The Impact of Glycosylated Hemoglobin and Diabetes Mellitus on Wound-Healing Complications and Infection After Foot and Ankle Surgery. Journal of the American Podiatric Medical Association, 104(4), 320-329. https://doi.org/10.7547/0003-0538-104.4.320

Article Metrics

Back to TopTop